FABRIS, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 11.489
AS - Asia 8.647
EU - Europa 6.390
SA - Sud America 1.520
AF - Africa 248
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 14
Totale 28.364
Nazione #
US - Stati Uniti d'America 11.170
SG - Singapore 3.006
IT - Italia 2.009
CN - Cina 1.921
BR - Brasile 1.161
VN - Vietnam 928
HK - Hong Kong 897
SE - Svezia 716
DE - Germania 598
KR - Corea 450
FR - Francia 397
BD - Bangladesh 372
RU - Federazione Russa 366
PL - Polonia 363
GB - Regno Unito 324
FI - Finlandia 297
NL - Olanda 296
IN - India 222
BG - Bulgaria 208
IE - Irlanda 185
UA - Ucraina 182
JP - Giappone 180
CA - Canada 158
TR - Turchia 146
AR - Argentina 137
MX - Messico 98
CH - Svizzera 90
ID - Indonesia 90
AT - Austria 88
ES - Italia 71
MA - Marocco 68
ZA - Sudafrica 57
IQ - Iraq 52
EC - Ecuador 50
PK - Pakistan 49
CO - Colombia 48
AU - Australia 46
IR - Iran 42
VE - Venezuela 33
SA - Arabia Saudita 32
EG - Egitto 30
PH - Filippine 30
RO - Romania 29
BE - Belgio 28
PE - Perù 28
TW - Taiwan 26
DK - Danimarca 23
KZ - Kazakistan 23
CL - Cile 21
MY - Malesia 21
SN - Senegal 21
TH - Thailandia 21
CZ - Repubblica Ceca 20
PY - Paraguay 20
DZ - Algeria 19
TN - Tunisia 17
UY - Uruguay 17
GR - Grecia 16
AE - Emirati Arabi Uniti 15
UZ - Uzbekistan 15
JO - Giordania 12
KE - Kenya 12
AZ - Azerbaigian 11
JM - Giamaica 11
AL - Albania 10
IL - Israele 10
MK - Macedonia 10
CR - Costa Rica 9
EU - Europa 9
LT - Lituania 9
NZ - Nuova Zelanda 9
HU - Ungheria 8
LB - Libano 8
NP - Nepal 8
BH - Bahrain 7
OM - Oman 7
PA - Panama 7
RS - Serbia 7
SV - El Salvador 7
DO - Repubblica Dominicana 6
HR - Croazia 6
KG - Kirghizistan 6
MN - Mongolia 6
PT - Portogallo 6
BO - Bolivia 5
GT - Guatemala 5
LA - Repubblica Popolare Democratica del Laos 5
NI - Nicaragua 5
NO - Norvegia 5
CY - Cipro 4
HN - Honduras 4
KW - Kuwait 4
LV - Lettonia 4
NG - Nigeria 4
PR - Porto Rico 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
BA - Bosnia-Erzegovina 3
CM - Camerun 3
Totale 28.311
Città #
Singapore 1.829
Ashburn 1.531
Fairfield 909
Hong Kong 860
San Jose 781
Chandler 669
Woodbridge 628
Wilmington 463
Houston 445
Seattle 445
Beijing 430
Seoul 424
Ann Arbor 408
Hefei 381
Trieste 321
Ho Chi Minh City 309
Cambridge 291
Boardman 265
Princeton 259
Chicago 244
Jacksonville 223
Sofia 206
Los Angeles 203
Milan 202
Santa Clara 198
Helsinki 195
Lauterbourg 181
Hanoi 180
Dublin 178
Zgierz 169
Moscow 165
Columbus 161
Council Bluffs 157
Warsaw 156
New York 142
The Dalles 136
Dallas 128
Rome 107
Frankfurt am Main 97
London 97
Tokyo 97
Buffalo 96
São Paulo 83
Munich 78
Nuremberg 78
Izmir 71
Shanghai 70
Dearborn 63
San Diego 63
Montreal 52
Venezia 50
Bern 48
Mumbai 44
Washington 44
Turin 42
Vienna 41
Düsseldorf 40
Da Nang 39
Orem 39
Rostock 39
Grafing 38
Guangzhou 38
Toronto 38
Lappeenranta 37
Haiphong 36
Atlanta 35
Johannesburg 35
Redwood City 34
Mexico City 32
Miano 32
Redondo Beach 31
Rio de Janeiro 31
Turku 31
Naples 30
Amsterdam 29
Casablanca 28
Shenzhen 27
Dong Ket 26
Jinan 26
Brooklyn 25
Denver 25
Bologna 24
Brussels 24
Phoenix 24
Chennai 23
Des Moines 23
Istanbul 23
Nanjing 23
Jakarta 22
Madrid 22
Dakar 21
Zurich 21
Baghdad 20
Belo Horizonte 20
Guayaquil 20
Tianjin 20
Dhaka 19
Florence 19
Lima 19
Bremen 18
Totale 17.419
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 547
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial 545
Consulenza cardiologica e gestione perioperatoria del paziente cardiopatico. Protocollo dell’Azienda Sanitaria Universitaria Integrata di Trieste – Anno 2019 436
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 406
Coronary covered stents 338
Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients 301
Riabilitazione cardiologica ambulatoriale a Trieste: Protocolli, attività  ed esiti 299
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 283
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 276
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 273
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 269
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 267
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 262
Balloon valvuloplasty after Transcatheter Aortic Valve Implantation (TAVI): always safe? 259
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 258
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 256
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 255
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 254
Treatment of Functional Mitral Regurgitation in Heart Failure 248
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 246
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 245
Impact of patient delay in a modern real world STEMI network 245
The role of clinical observation: Red flag 5-right ventricular involvement, arrhythmogenic right ventricular cardiomyopathy and associated phenotypes 233
The role of clinical observation: Red flag 1-cardiomyopathies and skeletal muscle involvement 233
A 20-year experience in cardiac tumors: a single center surgical experience and a review of literature 229
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 225
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 222
Prognostic Role of Left Ventricular Dysfunction in Patients With Coronary Artery Disease After an Ambulatory Cardiac Rehabilitation Program 222
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]. 219
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 219
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 218
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 217
Bilateral coronary obstruction in high-risk transcatheter aortic valve-in-valve implantation: When procedural strategy counts 214
Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study 212
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis 211
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 209
Angiopatia amiloide cerebrale e occlusione dell’auricola sinistra: evidenze e possibili linee operative per un approccio collaborativo fra Cardiologia e Neurologia 203
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 202
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 198
The role of clinical observation: red flag 8 - Cardiomyopathies in the first year of life and pediatric cardiomyopathies. 194
Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome. 194
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 192
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 191
Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy 191
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 190
Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention 184
Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm 183
Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation 174
Clinical Spectrum of PRKAG2 Syndrome 171
If heart failure or cardiac arrest complicate pregnancy and delivery 170
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry 168
Does extracorporeal cardiopulmonary resuscitation improve survival with favorable neurological outcome in out-of-hospital cardiac arrest? A systematic review and meta-analysis 167
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 167
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 166
Nonatherosclerotic Coronary Artery Narrowing 165
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity 165
Thoracic pain: Clinical features 165
Effect of prehospital treatment in STEMI patients undergoing primary PCI 163
La cardiomiopatia dilatativa non sempre è evolutiva: come evitare decisioni errate? 162
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 162
Insufficienza tricuspidale e indicazioni al trattamento 161
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 160
Three-vessel coronary artery disease evaluation by multimodality imaging with near-infrared spectroscopy (NIRS) plus intravascular ultrasound (IVUS) and optical coherence tomography (OCT) 156
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 156
The evolution of cardiology: Changes, future challenges and opportunities 155
Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry 154
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: Insights from the ATLANTIC trial 154
Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres 153
Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study 152
Early prognostic stratification and identification of irreversibly shocked patients despite primary percutaneous coronary intervention 151
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 148
Direct cellular reprogramming: the hopes and the hurdles 147
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction 147
Cardiac amyloidosis: do not forget to look for it 146
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 145
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial 143
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 143
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 142
Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target? 141
Supraventricular Tachycardia Causing Left Ventricular Dysfunction 141
Endomyocardial fibrosis of the right ventricle: A case report of successful surgery 140
Near-infrared spectroscopy-intravascular ultrasound: Scientific basis and clinical applications 139
Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS 139
International Subspecialty Fellowship Training, the Path for Cardiologists of Tomorrow?: A European Perspective 137
A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the “DAPT-STEMI trial” 137
Prognostic impact of treatments evolution in STEMI 136
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study 136
null 135
In-hospital evolution of secondary mitral regurgitation in acutely decompensated heart failure 133
Implantable-cardioverter-defibrillator after ST-elevation myocardial infarction: when and how frequently is it implanted and what is the rate of appropriate interventions? Insight from Trieste registry 131
null 131
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 129
Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial 129
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective 128
The impact of COVID-19 on myocardial infarctions, strokes and out-of-hospital cardiopulmonary arrests: an observational retrospective study on time-sensitive disorders in the Friuli Venezia Giulia region (Italy) 128
Hat-Marker Orientation to Minimize Neo-Commissural Overlap With Coronaries During CoreValve Evolut TAVR 128
Angiography and electrocardiography (ECG) for the assessment of coronary microvascular obstruction 128
Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction 127
Might midodrine be useful in patients with decompensated and worsening chronic heart failure? Author's reply 126
Optical coherence tomography for strategy planning and staged optimization of spontaneous coronary artery dissection 125
Totale 19.775
Categoria #
all - tutte 89.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 0 0 0 0 0 0 193
2021/20221.650 69 104 64 70 122 153 76 65 227 142 160 398
2022/20232.229 216 295 256 264 163 387 40 141 257 38 128 44
2023/20242.039 106 95 76 119 147 231 292 390 29 112 222 220
2024/20255.471 189 428 535 429 456 674 333 263 561 639 419 545
2025/202612.144 924 668 962 1.517 900 1.015 1.479 504 1.204 1.603 721 647
Totale 29.170